Skip to main content

Table 1 Participant characteristics and neuropsychological performance

From: Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an 11C altropane positron emission tomography study

 

PD subjects

DLB subjects

HCS

n

19

10

17

Age (years)

70.1 ± 7.0

72.1 ± 6.2

73.9 ± 6.7

Gender (female/male)

7/12a

1/9b

10/7a

Education (years)

16.4 ± 3.2

16.4 ± 3.5

16.2 ± 2.9

l-Dopamine equivalent dose (mg)

476.2 ± 379.8c

256.0 ± 280.3

0d

Hoehn and Yahr stage

2.5 ± 0.4c

2.25 ± 1.1c

0e

Unified Parkinson Disease Rating Scale

20.9 ± 7.4 f

30.3 ± 2.9b

1.2 ± 2.5e

Duration of motor symptoms (years)

8.6 ± 5.1a

3.0 ± 0.7d

-

Mini-Mental State Examination

28.1 ± 2.4a

19.3 ± 9.2b

28.9 ± 1.5a

Clinical Dementia Rating Scale - sum of boxes

0.4 ± 0.6a

7.2 ± 3.7b

0.1 ± 0.2a

Aggregate cognitive domain factors

   

Executive

   

Trailmaking Test B (seconds)

112.4 ± 67.7a

298.8 ± 3.0b

73.3 ± 27.7a

Digit Symbol

41.3 ± 9.0a

14.1 ± 11.1b

47.8 ± 21.6a

Episodic memory

   

Logical Memory I

12.9 ± 5.4a

5.6 ± 1.5b

16.5 ± 3.8a

Logical Memory II

12.1 ± 6.0a

5.4 ± 4.9b

16.1 ± 4.1a

Semantic memory and language

   

Free Selective Reminding Test

28.8 ± 6.0a

18.4 ± 10.0b

32.9 ± 6.2a

Free and Cued Selective Reminding Test

47.0 ± 1.6

45.3 ± 2.6

46.3 ± 4.0

Boston Naming Test

27.7 ± 1.7a

23.1 ± 7.9b

27.9 ± 3.0a

Letter Fluency

44.9 ± 12.4a

24.0 ± 14.1b

52.7 ± 12.2a

Category Fluency

31.8 ± 6.9a

13.9 ± 9.5b

38.9 ± 15.0a

Visuospatial skills

   

Visual Form Discrimination Test

28.9 ± 3.5a

24.7 ± 5.0b

30.6 ± 2.4

  1. Values presented as mean ± standard deviation. PD, Parkinson disease without dementia; DLB, dementia with Lewy bodies; HCS, healthy control subjects. Significant differences (P<0.05) between groups are indicated as follows: adifferent from DLB; bdifferent from PD and HCS; cdifferent from HCS; ddifferent from PD; edifferent from PD and DLB; and fdifferent from DLB and HCS.